Comgest Growth Europe ex UK GBP SU H AccRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 12.5 | 32.8 | -21.6 | 25.5 | 1.1 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 20/11/2024 | GBP 26.18 | |
Day Change | -0.08% | |
Morningstar Category™ | Other Equity | |
IA (formerly IMA) Sector | Europe Excluding UK | |
ISIN | IE00BRTM4M55 | |
Fund Size (Mil) 20/11/2024 | GBP 253.52 | |
Share Class Size (Mil) 20/11/2024 | GBP 31.73 | |
Max Initial Charge | - | |
Ongoing Charge 04/06/2024 | 0.97% |
Investment Objective: Comgest Growth Europe ex UK GBP SU H Acc |
The investment objective of the Fund is to achieve capital appreciation by creating a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies having their headquarters or carrying out their predominant activities in any European country with the exception of the United Kingdom. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Franz Weis 18/12/2014 | ||
Denis Callioni 30/08/2024 | ||
Click here to see others | ||
Inception Date 18/12/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Ex UK NR EUR | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Comgest Growth Europe ex UK GBP SU H Acc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 6.82 |
ASML Holding NV | Technology | 6.75 |
Essilorluxottica | Healthcare | 5.40 |
Schneider Electric SE | Industrials | 4.75 |
Alcon Inc | Healthcare | 4.44 |
Increase Decrease New since last portfolio | ||
Comgest Growth Europe ex UK GBP SU H Acc |